Kasetsuwan and associates recently published a randomized clinical trial on the use of PACK (Photoactivated chromophore for keratitis) cross-linking (CXL) for moderate to severe infectious keratitis. The authors compared 2…

We appreciate Hanumunthadu and associates’ interest in our recently published manuscript, “Response of pigment epithelial detachment to anti–vascular endothelial growth factor treatment in neovascular age-related macular degeneration.” They have presented…

We read with great interest the article describing treatment response of pigment epithelial detachment (PED) to anti–vascular endothelial growth factor (anti-VEGF) treatment in neovascular age-related macular degeneration (nAMD) by Cho…

We thank Drs Dan and Mihai Călugăru for their interest and comments regarding our recent publication titled “Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema.” As…

The study by Rahimy and associates assessed the short-term visual and anatomic outcomes of patients with persistent diabetic macular edema (DME) who were converted from bevacizumab (Avastin; Genentech, Inc, South…

We wish to thank Dr Uzun for his letter and his valuable remarks regarding our recently published article. Dr Uzun writes, summarizing our article, that we did not determine any…

I read and reviewed the article entitled “Swept-source optical coherence tomography correlations between retina and choroid before and after vitrectomy for epiretinal membranes,” by Michalewska and associates, with interest. The…

We thank Drs Uzun and Pehlivan for showing interest in our paper. Unfortunately, the axial length was not evaluated in our study. Therefore, it is not possible to clarify the…

We have read and reviewed the article entitled “Short-Term Changes in Choroidal Thickness After Aflibercept Therapy for Neovascular Age-Related Macular Degeneration,” by Koizumi and associates, with interest. Choroidal thickness (CT)…